Bayesian therapeutic drug monitoring software: past, present and future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bayesian therapeutic drug monitoring software: past, present and future

Published:2018-12-01 Issue:4 Volume:3 Page:109-114
ISSN:2053-0846
Container-title:International Journal of Pharmacokinetics
language:en
Short-container-title:International Journal of Pharmacokinetics

Author:

Drennan Philip¹,Doogue Matthew²³,van Hal Sebastiaan J¹,Chin Paul²³

Affiliation:

1. Department of Microbiology & Infectious Diseases, Royal Prince Alfred Hospital, Sydney, Australia

2. Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand

3. Christchurch School of Medicine, University of Otago, Christchurch, New Zealand

Publisher

Future Science Ltd

Link

http://www.future-science.com/doi/pdf/10.4155/ipk-2018-0005

Reference20 articles.

1. Safe and Effective Variability—A Criterion for Dose Individualization

2. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis – a population pharmacokinetic study

3. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

4. Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides

5. Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring;The Journal of Clinical Pharmacology;2022-12-29

2. Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill;Critical Care Research and Practice;2022-11-17

3. Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels;Journal of Infection;2022-10

4. Personalized tobramycin dosing in children with cystic fibrosis: a comparative clinical evaluation of log-linear and Bayesian methods;Journal of Antimicrobial Chemotherapy;2022-09-29

5. Application of Machine Learning Classification to Improve the Performance of Vancomycin Therapeutic Drug Monitoring;Pharmaceutics;2022-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3